Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma
Clinical trial NCT04002622 · TERMINATED
Trial details
- NCT number
- NCT04002622
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2021-01-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.